Stay updated on Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    A new revision entry Revision: v3.5.3 was added to the history, and the prior Revision: v3.5.2 entry is no longer present. This marks an update to the page version of the record.
    Difference
    0.1%
    Check dated 2026-04-30T18:43:46.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed from the record history.
    Difference
    0.1%
    Check dated 2026-04-16T10:56:39.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Added revision v3.5.0 to the record history and removed revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T17:53:53.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added a new revision entry v3.4.3 and removed v3.4.2 from the record history.
    Difference
    0.1%
    Check dated 2026-03-11T16:36:00.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    A new revision (v3.4.2) was added and an older government funding notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1.0%
    Check dated 2026-02-11T02:30:32.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    The update adds a general funding status notice and updates the page software from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1.0%
    Check dated 2026-02-03T23:35:48.000Z thumbnail image

Stay in the know with updates to Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial page.